There was no significant relationship between ERCC1 expression and sex or site of primary tumor (pancreatic head or body/tale) or metastatic sites (lymph nodes, liver or multiple sites) or previous adjuvant treatment. This evidence concerns the gene ERCC1 and neoplasm.